1. Home
  2. NVAX vs ASST Comparison

NVAX vs ASST Comparison

Compare NVAX & ASST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$6.75

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Asset Entities Inc. Class B

ASST

Asset Entities Inc. Class B

HOLD

Current Price

$0.89

Market Cap

913.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
NVAX
ASST
Founded
1987
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
913.3M
IPO Year
1995
2023

Fundamental Metrics

Financial Performance
Metric
NVAX
ASST
Price
$6.75
$0.89
Analyst Decision
Hold
Strong Buy
Analyst Count
8
1
Target Price
$9.75
$1.50
AVG Volume (30 Days)
3.3M
85.3M
Earning Date
11-06-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.07
N/A
Revenue
$1,064,651,000.00
$5,512,106.00
Revenue This Year
$58.91
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$3.22
N/A
Revenue Growth
20.27
125.01
52 Week Low
$5.01
$0.78
52 Week High
$11.55
$7.89

Technical Indicators

Market Signals
Indicator
NVAX
ASST
Relative Strength Index (RSI) 43.34 40.62
Support Level $6.36 $0.78
Resistance Level $6.76 $1.04
Average True Range (ATR) 0.22 0.08
MACD 0.05 0.01
Stochastic Oscillator 47.39 32.75

Price Performance

Historical Comparison
NVAX
ASST

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

About ASST Asset Entities Inc. Class B

Strive Inc is engaged in providing investment advisory, wealth management, and consulting services through its subsidiary. Its objectives is to (i) accumulate Bitcoin; (ii) increase Bitcoin-per-share; and (iii) outperform Bitcoin over the long run by deploying both beta Bitcoin treasury accumulation strategies and alpha investment strategies with the goal of beating Bitcoin's investment performance as the hurdle rate.

Share on Social Networks: